• Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

      Urayama, Kevin Y; Jarrett, Ruth F; Hjalgrim, Henrik; Diepstra, Arjan; Kamatani, Yoichiro; Chabrier, Amelie; Gaborieau, Valerie; Boland, Anne; Nieters, Alexandra; Becker, Nikolaus; et al. (Journal of the National Cancer Institute, 2012-02-08)
      Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein-Barr virus (EBV) status. This potential etiological heterogeneity is not recognized in current disease classification.